Release Date: 17/12/15 12:48 Summary: Becoming a substantial holder from CBA Price Sensitive: No Download Document 1.05MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%